April 28 - May 1 | Palma de Mallorca, ES
April 28 - May 1 | Palma de Mallorca, ES
April 28 - May 1 | Palma de Mallorca, ES
April 28 - May 1 | Palma de Mallorca, ES
April 28 - May 1 | Palma de Mallorca, ES
Abstract submission
Notifications regarding acceptance or rejection of submitted abstracts will be available by mid-February.
All presenting authors of oral and poster presentations, are expected to register for and attend ECIO 2024. Poster presenters need to complete and pay their registration by April 15, otherwise the poster will be withdrawn from the programme of ECIO 2024. Costs associated with the submission and presentation of an abstract are the responsibility of the presenter.
To view your submission, please click on the corresponding link below.
Poster Awards
The winners of the Poster Awards will be selected by the ECIO Scientific Programme Committee.
All winners of poster awards will
- receive an invitation to submit a manuscript to CVIR
- be published on CIRSE’s social media
- receive a certificate
In addition, the presenter of the poster receiving the Magna Cum Laude Award will
- receive free registration for a CIRSE 2024 or 2025 congress of their choice
- be interviewed for the CIRSE Insider
Best Scientific Paper Award
The best scientific paper will be selected by ECIO congress attendees. Its presenter will
- receive free registration for a CIRSE 2024 or 2025 congress of their choice
- be invited to submit a manuscript to CVIR
- be interviewed for the CIRSE Insider
Publication in CVIR
All accepted abstracts will be published in a special supplement of CVIR, the longest-running journal in the field of vascular and interventional radiology. An opportunity not to be missed!
Submitting your abstract to ECIO will enable you to share your work at the world’s most comprehensive interventional oncology meeting.
All accepted abstracts will be published in a special supplement of CVIR, the longest-running journal in the field of vascular and interventional radiology. An opportunity not to be missed!
In order to further support research in interventional oncology, a new abstract submission category will be added for ECIO 2022: FIRST@ECIO Clinical Trial will allow physicians to submit abstracts from clinical trials with prospective study design first presented at ECIO.